Fahr’s Disease: A Response To Patient Perspectives of Presentation and Clinical Expectations
Objective: This e-poster will provide insights into the patient perspectives of presentation and diagnostic/management process for their condition. It will also explore how Fahr Beyond…Whispers of Hope Motor and Psychiatric Recovery in Fahr’s Disease with High-Frequency rTMS: A Case Report
Objective: To present a case of FD showing significant motor and psychiatric improvement following high-frequency rTMS of the DLPFC Background: Fahr’s disease (FD) is a…Loneliness accelerates parkinsonism decline in parkinsonian community-dwelling older adults
Objective: To determine the longitudinal impact of loneliness on parkinsonism, relative to the longitudinal impact of parkinsonism on loneliness, in parkinsonian adults. Background: The link…Peripheral unspecific inflammatory parameters – not always useful in differential diagnosis of parkinsonian syndromes.
Objective: To determine utility of systemic inflammation response index (SIRI) and systemic immune-inflammation index (SII) in differential diagnosis of Parkinson’s disease (PD), progressive supranuclear palsy-Richardson’s…Exploring Cardiac Autonomic Dysfunction in Synucleinopathies with Parkinsonism Across Awake-Sleep Stages
Objective: To explore the differences in heart rate variability (HRV) across awake-sleep stages between patients with synucleinopathies and elderly controls without parkinsonism Background: A complex…Deep Brain Stimulation in a Patient with Dystonia-Parkinsonism Secondary to a c.609G>A PLA2G6-Associated Neurodegeneration Variant
Objective: To describe a rare likely pathogenic variant of the PLA2G6 protein and its response to deep brain stimulation (DBS). Background: PLA2G6-associated neurodegeneration (PLAN) can…Retention & Safety in a Home-Based Fracture Prevention Trial of Zoledronate vs Placebo (TOPAZ) in Persons with Neurodegenerative Parkinsonism (NDP)
Objective: To assess retention and safety in the ongoing TOPAZ trial, NCT03924414 Background: People with NDP face a four-fold increased fracture risk, yet preventive treatment…Utilization of Phosphorylated Alpha-Synuclein Skin Biopsy Testing in a Movement Disorders Center
Objective: To describe the utilization patterns of skin biopsy for phosphorylated alpha-synuclein (P-syn) aggregation obtained from three sites (posterior cervical, distal thigh, distal leg) and…Nasal septum deviation correlates with asymmetry in Parkinson’s disease
Objective: To assesse whether asymmetry in the nasal cavity is related to dopaminergic dysfunction asymmetry in PD patients Background: Asymmetry in motor dysfunction and associated dopaminergic…The regulatory variant c.–253C>T of the DNAJC13 gene as a causal factor for Parkinson’s disease in a patient with early-onset
Objective: This work aims to investigate the role of regulatory regions in Parkinson’s disease (PD) genes, which may help explain part of the missing heritability.…
- 1
- 2
- 3
- …
- 405
- Next Page »